News - Nodus Oncology

News

Latest news and press releases from Nodus Oncology

Nodus Oncology presents its PARG inhibitor preclinical data at the ENA meeting in Barcelona

Nodus Oncology raises £1.8m ($2.3m) to extend its seed funding

Nodus Oncology announces the appointment of Thomas Wirth as Chief Business Officer

Nodus Oncology announces the appointment of Dominic James as Chief Scientific Officer

Nodus Oncology announces the appointment of Keith Caldecott as Scientific Advisory Board member

Nodus Oncology secures £2.4m ($2.9m) Investment

Nodus Oncology announces its Board of Directors

Nodus Oncology announces Scientific Advisory Board members

Nodus Oncology announces acquisition of Basilea Pharmaceutica’s PARG inhibitor programme

Nodus Oncology launches, founded by Cumulus Oncology and in partnership with the Lead Discovery Center, to focus on developing first- and best-in-class molecules inhibiting novel DNA damage response targets

Would you like to learn more about Nodus Oncology?

Contact us